Literature DB >> 22749794

Ghrelin signalling and obesity: at the interface of stress, mood and food reward.

Harriët Schellekens1, Beate C Finger, Timothy G Dinan, John F Cryan.   

Abstract

The neuronal circuitry underlying the complex relationship between stress, mood and food intake are slowly being unravelled and several studies suggest a key role herein for the peripherally derived hormone, ghrelin. Evidence is accumulating linking obesity as an environmental risk factor to psychiatric disorders such as stress, anxiety and depression. Ghrelin is the only known orexigenic hormone from the periphery to stimulate food intake. Plasma ghrelin levels are enhanced under conditions of physiological stress and ghrelin has recently been suggested to play an important role in stress-induced food reward behaviour. In addition, chronic stress or atypical depression has often demonstrated to correlate with an increase in ingestion of caloric dense 'comfort foods' and have been implicated as one of the major contributor to the increased prevalence of obesity. Recent evidence suggests ghrelin as a critical factor at the interface of homeostatic control of appetite and reward circuitries, modulating the hedonic aspects of food intake. Therefore, the reward-related feeding of ghrelin may reveal itself as an important factor in the development of addiction to certain foods, similar to its involvement in the dependence to drugs of abuse, including alcohol. This review will highlight the accumulating evidence demonstrating the close interaction between food, mood and stress and the development of obesity. We consider the ghrelinergic system as an effective target for the development of successful anti-obesity pharmacotherapies, which not only affects appetite but also selectively modulates the rewarding properties of food and impact on psychological well-being in conditions of stress, anxiety and depression.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22749794     DOI: 10.1016/j.pharmthera.2012.06.004

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  58 in total

Review 1.  The microbiome: stress, health and disease.

Authors:  Rachel D Moloney; Lieve Desbonnet; Gerard Clarke; Timothy G Dinan; John F Cryan
Journal:  Mamm Genome       Date:  2013-11-27       Impact factor: 2.957

2.  Gut feelings about depression.

Authors:  Alfonso Abizaid; Hymie Anisman
Journal:  J Psychiatry Neurosci       Date:  2014-11       Impact factor: 6.186

Review 3.  Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour.

Authors:  John F Cryan; Timothy G Dinan
Journal:  Nat Rev Neurosci       Date:  2012-09-12       Impact factor: 34.870

Review 4.  From gut changes to type 2 diabetes remission after gastric bypass surgeries.

Authors:  Bing Li; Xinrong Zhou; Jiarui Wu; Huarong Zhou
Journal:  Front Med       Date:  2013-04-04       Impact factor: 4.592

Review 5.  Neuroendocrine circuits governing energy balance and stress regulation: functional overlap and therapeutic implications.

Authors:  Yvonne M Ulrich-Lai; Karen K Ryan
Journal:  Cell Metab       Date:  2014-03-13       Impact factor: 27.287

Review 6.  Anxiety, Depression, and the Microbiome: A Role for Gut Peptides.

Authors:  Gilliard Lach; Harriet Schellekens; Timothy G Dinan; John F Cryan
Journal:  Neurotherapeutics       Date:  2018-01       Impact factor: 7.620

Review 7.  Mood disorders: A potential link between ghrelin and leptin on human body?

Authors:  Stalo Zarouna; Greta Wozniak; Anastasia Ioannis Papachristou
Journal:  World J Exp Med       Date:  2015-05-20

Review 8.  Minireview: Gut microbiota: the neglected endocrine organ.

Authors:  Gerard Clarke; Roman M Stilling; Paul J Kennedy; Catherine Stanton; John F Cryan; Timothy G Dinan
Journal:  Mol Endocrinol       Date:  2014-06-03

9.  Negative affect is associated with increased stress-eating for women with high perceived life stress.

Authors:  Rebecca R Klatzkin; Reedhi Dasani; McKay Warren; Catrina Cattaneo; Tzvi Nadel; Cleo Nikodem; Harry R Kissileff
Journal:  Physiol Behav       Date:  2019-08-01

10.  Fasting-induced increase in plasma ghrelin is blunted by intravenous alcohol administration: a within-subject placebo-controlled study.

Authors:  Lorenzo Leggio; Melanie L Schwandt; Emily N Oot; Alexandra A Dias; Vijay A Ramchandani
Journal:  Psychoneuroendocrinology       Date:  2013-09-13       Impact factor: 4.905

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.